Click here to read this study in JAMA Cardiology. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
1. There were no serious adverse effects on device function post-magnetic resonance imaging (MRI) in non-MRI conditional implantable defibrillator (ICD) ...
1. In this randomized controlled trial, subcutaneous implantable cardioverter defibrillators (S-ICD) resulted in a lower risk of perioperative complications as ...
1. In this retrospective cohort study, among 504 patients with biopsy proven sarcoidosis who underwent cardiovascular magnetic resonance imaging (CMR), ...
1. The subcutaneous implantable cardioverter-defibrillator (ICD) was shown to be noninferior to the transvenous ICD for device-related complications in patients ...
1. In this multicenter, longitudinal, serial cross-sectional analysis, there were 457 hospitals across 43 states that reached a monetary settlement ...
1. Adults with chronic kidney disease (CKD) and heart failure with reduced LVEF who received implantable cardioverter defibrillators (ICDs) did ...
1. Patients with ICD therapy had an overall reduction in all-cause mortality compared to conventional care. 2. The rate of ...
